Concepedia

Publication | Open Access

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma

117

Citations

36

References

2019

Year

References

YearCitations

Page 1